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ABSTRACT 
 
 
When a human or animal is threatened or confronted with a stimuli signalling danger, 
internal defence mechanisms are activated that evoke feelings of fear and anxiety. These 
emotional responses promote the behaviour patterns necessary for an organism’s 
survival. Animal research seeks to understand how these emotions affect behaviour both 
physiologically and neurologically in order to develop effective treatment for those 
suffering from severe anxiety disorders. The aim of this thesis was to examine the role of 
the amygdala, and dorsal and ventral hippocampus in relation to immediate fear arousal 
brought on by footshock. This was assessed by examining whether muscimol would 
interfere with the acoustic startle response before or after footshock presentation, and 
then comparing these reactions to a control group that received saline infusions. The 
results of this research are extremely important because they identify various brain 
structures involved in the fear-arousing effects of footshock as measured by the shock 
sensitization of acoustic startle. Laboratory rats received muscimol (0.1ug and 0.01ug) 
infusions into the basolateral amygdala, dorsal and ventral hippocampus. These three 
brain regions have been identified as playing a prominent role in fear neurocircuitry. The 
results demonstrated that the GABA A receptor agonist muscimol in doses of 0.1ug and 
0.01ug reliably blocked shock sensitization of the acoustic startle response. The 
muscimol doses did not alter the shock reactivity amplitudes therefore indicating a 
normal perception of the fear arousing properties of footshock. Therefore, the present 
study’s results suggest that a decrease of GABA activity in the amygdala, dorsal and 
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ventral hippocampus may be essential for the neuronal basis of fear acquisition and 
expression of unconditioned and conditioned stimuli.    
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1.0 INTRODUCTION 
1.1 The Emotion of Fear  
 
 Animals survive in nature through their effective innate defensive reactions. 
When an animal is confronted with a sudden or new stimulus it reacts immediately it 
either runs away (flees), freezes, or adopts an aggressive response (fight). These 
responses vary from animal to animal but they are automatic and without the thought that 
typifies humans (Bolles, 1970). Evolutionary theory proposes that an organism’s survival 
is dependent upon its ability to learn quickly and with little training (Öhman & Mineka, 
2001). The organism must learn to fear a potential stimulus that could threaten its 
survival. Learning is an adaptation that occurs when an organism must cope with the 
various environmental changes that occur throughout its lifetime. Permanent changes in 
the brain occur when an animal learns to fear a stimulus. Learned fear is different to 
sensitized fear in that learned fear requires a permanent change in the brain’s 
neurocircuitry, which is achieved through past encounters within aversive contexts 
(Öhman & Mineka, 2001).  
  
 The fear model states that fear is activated automatically by specific fear arousing 
stimuli. This automaticity of the defence response is important for an organism’s survival 
and ability to adapt to changing environments (Öhman & Mineka, 2001). A slight 
hesitation may be the difference between an organism living and procreating, or dying 
and ending the transmission of its genes to new generations. When confronted with 
danger an automatic rapid response is needed instead of a complex cognitive analysis of 
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the situation. People who suffer from severe phobias often recognise that the fear they 
experience is excessive and unreasonable. It is proposed that fear responding that is 
evoked by certain fearful or aversive stimuli are not influenced or changed by cognition; 
rather once the response is activated it runs its course of action (Öhman & Mineka, 
2001). The fear defence system is controlled by specific neuro-circuitry in the brain. 
Recognition that the fear mechanism has an ancient history suggests that those areas most 
likely to be involved would be located in the more primitive structures of the brain, such 
as the limbic system (Öhman & Mineka, 2001).   
 
1.2 How Fear is Measured in Animals 
  
 Fear is expressed through various behavioural modalities, such as verbally, 
cognitively, motorically, and physiologically. Experiments using selective association, 
selective sensitization, and latent inhibition only measure one or two of the fear response 
systems (Koch, 1999). It is thought that what closely relates to fear in an animal is the 
measurement of their defensive responding, such as increased heart rate, facial muscle 
activity, increased blood pressure, freezing, or the fear potentiated startle reflex response. 
Davis and his colleagues (1992) used the potentiation of the startle reflex to measure fear 
in their animals. Startle potentiation has been observed to occur many times when an 
animal has been fear conditioned to a fear potentiating stimulus. Fear potentiation is the 
startle reflex of the whole body of the animal. In humans eyeblink amplitudes have been 
readily used and observed (Koch, 1999). These various expressions of fear are the 
activation of defensive behavioural systems that rise in reaction to threatening stimuli. 
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These expressions of fear have all been identified as the most important components for 
inferring fear (Koch, 1999).     
 
1.3 The Acoustic Startle Response 
  
 The startle response can be obtained in many animals and humans; it causes the 
subject to react to a visual, acoustic, or tactile stimulus resulting in rapid movements of 
facial and body muscles (Landis & Hunt, 1939). The reaction begins with eyelid closure, 
then facial muscles contract moving to the neck and skeletal muscles (Koch, 1999). Other 
physiological reactions include an increase in heart rate, while other behaviours are 
slowed down and are less likely to occur. The startle response has been identified to 
perform a protective function from injury and predators; it also increases the likelihood of 
survival and prepares the organism for the fight/flight response (Koch, 1999). Despite 
startle’s simple nature it can be manipulated by a variety of variables. Startle has a non-
zero baseline which means it can be magnified and reduced (Koch, 1999). Therefore, 
many researchers have used startle as a behavioural tool to understand sensorimotor 
response plasticity (Koch, 1999). The greatest amount of research on the acoustic startle 
response (ASR) has taken place with mammals, namely rats, mice, cats, and humans 
(Koch, 1999). ASR research has found that the same stimulus parameters used on 
animals generate the exact same response patterns in humans (Koch, 1999). Results from 
many animal studies have been generalised to humans. Due to the parallel similarity 
found among rats and humans, it has been proposed that the neuronal mechanisms 
involved in the ASR may help explain human sensorimotor integration (Koch, 1999).  
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 The ASR varies in stimulus intensity and inter-stimulus interval which affects the 
startle magnitude and latency. The ASR varies among participants and can be influenced 
by genetic differences such as diurnal rhythm, the sensory environment, background 
noise, illumination pre-pulses, and various drugs (Koch, 1999). The ASR can be 
magnified or enhanced by conditioned and unconditioned aversive stimuli. The ASR can 
be modified through the variation of experimental conditions and by manipulating the 
perceptual and emotional state of the organism (Davis, 1996; Davis, Walker, & Yee, 
1997). Drugs have been widely used to change the magnitude of the ASR and to assess 
effects on sensorimotor reactivity in both animals and humans (Davis, 1980; Davis, Falls, 
Campeau, & Kim, 1993). For example, anxiogenic drugs such as yohimbine reduce the 
inhibitory neurotransmission of the CNS and heighten the ASR (Fendt & Schnitzer, 
1994). In contrast, drugs that decrease the excitability of the CNS, such as ethanol or 
diazepam inhibit the ASR (Berg & Davis, 1984; Grillon, Sinha, & O’Malley, 1994). The 
infusion of these different drugs into specific brain structures has brought about a number 
of investigations of the various pathways that mediate and moderate the ASR. Such 
manipulations are thought to either enhance or inhibit the transfer of information between 
sensory receptors and motor effector systems (Koch, 1999).    
  
 Because startle is assumed to have a protective function against predators and 
survival, it is proposed that in a threatening situation or aversive event, the ASR is 
enhanced as a result. It is readily observed that when experimental rats are presented with 
an aversive event the ASR is consistently enhanced (Koch, 1999). Research utilising rats 
has demonstrated that when an animal is presented with a cue predicting an aversive 
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event (fear potentiated startle), the presentation of bright illumination, electric footshock 
or a loud noise results in the enhancement of startle (Davis, 1989). Other research has 
found that the ASR has been observed to increase after lesions of the septum, olfactory 
bulbectomy, and stimulation of the amygdala, VTA and the lateral periaqueductal area. 
The infusion of drugs into particular brain structures can also enhance or reduce the 
magnitude of the ASR (Davis, 1980).       
 
1.4 Sensitization 
  
 Sensitization is achieved in a short time frame when an enhanced response to fear 
stimuli occurs after the fear state has already been activated. Öhman and his colleagues 
(2001) discovered that fear-relevant stimuli elicit an increase in stimulus conditioned 
response (SCR) in contrast to fear-irrelevant stimuli, and the threat of electric shock 
augments the response. Sensitization refers to the enhancement of a response after the 
presentation of a strong stimulus. The majority of ASR sensitization research is based on 
a dishabituation design. This posits that the magnitude of the ASR pre-shock habituates 
due to repeated presentation of startling stimuli and is compared to the ASR after the 
footshocks. However, Davis (1989) shows in his studies that aversive shocks increase the 
ASR magnitude way above the initial level (pre-shock, before habituation occurs). The 
term sensitization refers to this notion, enhancement of the ASR before habituation 
occurs. Sensitization is a non-associative form of learning due to the fact that the subject 
does not associate a particular event with an aversive stimulus. Researchers suggest that 
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the underlying mechanisms of sensitization in the acoustic startle response are similar to 
that of the fear-potentiated startle reflex.  
  
 Some researchers have put forward the idea that animals are conditioned to 
various background noise during ASR experiments (Fendt & Fanselow, 1999; 
Richardson, 2000). Richardson and Elsayed (1998) found that shock sensitization of the 
ASR is mediated by context conditioning. They used two manipulation experimental 
designs that reduced the conditioning to the test context, and proposed that the 
manipulations would have little effect if shock sensitization is mediated by unconditioned 
fear (Richardson & Elsayed, 1998). Their results suggest that the shock sensitization 
paradigm is in fact mediated by contexual conditioning rather than a state of fear that is 
unconditionally elicited by shock. Animals shocked in a different context than the testing 
environment, or given extensive pre-exposure to the test context previous to shock did 
not exhibit sensitization of the startle response (Richardson & Elsayed, 1998).          
 
1.5 Pavlovian Fear Conditioning 
  
 Seligman’s theory of fear acquisition proposes that intense fear can be established 
through Pavlovian Conditioning for stimuli that have threatened an organism’s survival 
in the past in comparison to stimuli that have never been a threat (fear irrelevant stimuli), 
or fear stimuli that have only recently emerged in our lifetime (fear relevant stimuli, eg. 
guns, cars, electric outlets, (Öhman & Mineka, 2001). Prepared associations are easy to 
acquire and require only one trial of learning, but they are more resistant to extinction in 
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comparison to non-prepared associations (Öhman & Mineka, 2001).  Seligman’s theory 
has been supported by many animal studies regarding many types of learning including 
fear conditioning. The early premise of learning theorists such as Seligman, Thorndike, 
and Pavlov was that all conditioned stimuli and unconditioned stimuli combinations are 
learnt with relative ease (Öhman & Mineka, 2001).    
  
 The fear potentiated startle paradigm was developed in 1951 and has been further 
investigated by Davis and his colleagues (1993). It involves training animals to associate 
a neutral stimulus (light or tone) with an aversive stimulus (mild electric footshock, 
Koch, 1999). After the subject receives a number of these pairings the conditioned 
stimulus (CS) elicits a state of fear and is measured by the potentiation of the ASR. The 
state of fear is the conditioned response to the CS (light), and the potentiation is how the 
fear is measured in the animal (Koch, 1999). The presentation of the CS also produces 
other fear related reactions such as freezing, an increase in blood pressure, and 
bradycardia (Davis, 1992; Le Doux, 1996). Pavlovian conditioning is the most frequently 
used by many behavioural researchers. Pavlovian Conditioning involves 1 – 2 training 
sessions of 10 – 20 pairings of a 3.7 second light with a 0.5 second electric footshock of 
mild intensity (0.6mA), presented 3.2 seconds after the onset of the light. Fear 
conditioning tests are typically performed 4 – 24 hours after conditioning (Koch, 1999). 
The initial fear test consists of tone or noise alone trials in the absence of the light to get 
animals consistently responding to the noise (ASR). Then the light is presented with the 
tone or noise trials later in the testing procedure. The difference in ASR magnitudes 
between the noise alone and light plus noise trials is the measure of fear that the animal 
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exhibits (Koch, 1999). Research has found that rats tend to show very low levels of the 
fear potentiated ASR when they have received very high levels (eg. 1.6mA) of electric 
footshock. This may be due to the high intensity of the footshock triggering an active 
instead of a passive defence mechanism that reduces the fear potentiated ASR (Walker & 
Davis, 1997).  
 
Contextual fear is another effect shown to occur in Pavlovian conditioning. In 
contextual fear the subject also begins to fear the context in which they receive the light 
and shock pairings. Contextual fear is also a conditioned effect and is acquired quite 
quickly (Fendt et al., 1999). The fear potentiated startle reflex can be blocked or 
interfered with by certain drugs. Some examples of such drugs are the benzodiazepine 
agonists, dopamine antagonists, and opioid agonists (Fendt et al., 1999). The properties 
and actions of these drugs have been shown to modify the animal’s state of fear. In 
particular, the anxiolytic effects of these drugs have been demonstrated in human studies 
(Davis, 1979; Davis et al., 1993; Fendt et al., 1999). Therefore, the fear potentiated startle 
reflex is a phenomenon that occurs across many species and has been observed in humans 
(Grillon & Davis, 1997). These findings lend support to the view that the expression of 
fear in humans and animals are similar in their underlying casual mechanisms.  
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1.6 The Role of the Amygdala in Fear 
 
 Ample research has demonstrated that the amygdala plays a regulatory role in an 
animal’s emotional response. The limbic system was thought to be primarily responsible 
for controlling the neural basis of emotion. However, this assumption soon diminished as 
specific nuclei and pathways of the limbic system emerged as playing key roles in 
memory and cognitive, as well as emotional functions (LeDoux, 1993). The limbic areas 
most important for emotional processes are less involved in cognitive processes. LeDoux 
(1996) has identified the amygdala as the central structure responsible for the neural fear 
circuitry which has more efferent than afferent connections within the cortex. Therefore, 
the amygdala sends out more information to the cortex than it actually receives. Animal 
research has found that in very stressful events the prefrontal cortex; where high levels of 
thinking takes place, shuts down and behaviour is then controlled by subcortical defence 
mechanisms. Human Positron Emission Tomogrophy (PET) studies have shown similar 
findings in that working memory in the prefrontal cortex areas are deactivated during 
extremely stressful situations (LeDoux, 1993).  
  
 A large number of studies have implicated the amygdala as the region of the 
mammalian brain responsible for fear processing. When certain emotional stimuli are 
presented to an animal, neurons in the amygdala become active. The efferent fibers of the 
central nucleus of the amygdala project through the stria terminalis and the ventral 
amygdalofugal pathway to areas in the diencephalons and brain stem, which have been 
identified as important in the expression of fear-related behaviour (LeDoux, 1987; Smith 
& De Vito, 1984). Electrical stimulation of the amygdala has been observed to enhance 
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startle amplitudes and also produce physiological changes such as elevated blood 
pressure that are apparent in fear episodes (Rosen & Davis, 1988; Davis, 1997). The 
pathway identified as controlling behavioural fear originates from fibres within the 
amygdala, which extend to the ventral periaqueductal gray in the midbrain (Fanselow, 
1994; Le Doux, Iwata, Chicchetti, & Reis, 1988). In contrast, the pathway important in 
producing physiological changes is identified as originating within the ventral 
amygdalofugal pathway and extends to the lateral hypothalamus. Therefore, the 
amygdala has been the primary focal point in fear research.  
  
 Research has established that the amygdala is an integral component in the 
expression of emotions for both animals and humans and that it contributes less to 
cognitive processing (Fendt & Fanselow, 1999; LeDoux, 1993). Both the amygdala and 
the hippocampus are involved in storing and retrieving memories about emotional 
experiences and events (LeDoux, 1993). LeDoux (1993) states that the differences 
between the amygdala and the hippocampus is based on the finding that the amygdala 
stores and retrieves emotional experience, while the hippocampus consolidates and 
retrieves non-emotional experiences. Research carried out in order to understand the 
underlying mechanisms involved in forming, establishing, and retrieving emotional 
experiences and memories have used the fear conditioning paradigm. Questions 
approached by this research has looked at how innate emotional responses are activated 
and controlled by environmental events, how learning of novel environments occur, and 
how information about aversive events are stored and used for future encounters of 
threatening environments (LeDoux, 1993).  
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1.7 Neurobiology of the Amygdala  
  
 The amygdala has been identified as being central to the neural circuitry 
employed in mediating and modulating fear behaviours for both humans and animals. It 
is located in front of the hippocampus and adjacent to the temporal lobe. The amygdala is 
made up of thirteen nuclei, containing numerous subnuclei (Pitkänen, 2000). The nuclei 
that have been identified as playing an integral role in fear include the basolateral 
complex (which consists of the lateral, basal, and accessory basal nuclei) and the central 
nucleus (which is divided into the capsular, lateral, and medial divisions). These nuclei 
are crucial to both sensory input and motor output for fear learning and memory systems, 
as well as behavioural responses to fear (Rosen, 2004). The nuclei of the basolateral 
complex is a rich sensory area that receives sensory input from the thalamus and cortex 
(Rosen, 2004). Within this complex, auditory and visual information is received via the 
lateral nucleus. The basolateral complex also receives various inputs from the 
hippocampus and the prefrontal cortex. The direction of information flow in the 
basolateral complex is generally lateral to medial, with extensive reciprocity and 
communication within the amygdala (Pitkänen, Savender, & LeDoux, 1997). It has been 
posited that the basolateral complex’s most prominent role is to interpret sensory 
information (Davis & Whalen, 2001); Rosen & Schulkin, 1998, which influences other 
amygdala nuclei and brain areas that produce a fear response. The lateral nucleus projects 
to the basal and accessory basal nuclei of the complex, and has direct efferent pathways 
to the central nucleus.  
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 The central nucleus of the amygdala has vast projections to nuclei found in the 
midbrain and brainstem, resulting in quick automatic behavioural and endocrine fear 
responses to possible threats of danger (Davis, 1992; Hostege, 1995). The prefrontal 
cortex innervates the central nucleus which controls the expression of learned behaviour 
(Quirk, Likhtik, Pelletier, & Pare, 2003). The central nucleus receives instinctual 
information from the brainstem and reciprocally projects the information to other brain 
areas. The central nucleus has various important roles in fear, it produces fear behaviour 
and receives instinctual information that in turn influences the central nucleus’s activity 
within the amygdala. Another important output pathway that has been identified is the 
basal nucleus efferent to the nucleus accumbens. Nauta and Domesick (1984) suggested 
that this pathway links motivation and motor control with organised active behaviour 
(Amorapanth, LeDoux, & Nader, 2000; Gray, 1999; Swanson, 2000; Swanson & 
Petrovich, 1998; Yim & Mogenson, 1982). Therefore, the central nucleus projections to 
the lower brain areas are responsible for reactive automatic behaviours, and endocrine 
fear responses such as freezing, while the efferents of the basal nucleus of the amygdala 
are involved in fear avoidant responses that are hypothesised to traverse the accumbens, 
striatum, and thalamus (Amorapanth et al., 2000). Recently, the medial nucleus of the 
amygdala has been shown to play a regulatory role in endocrine responses via efferent 
projections to the hypothalamus (Dayas, Buller, & Day, 1999).  
  
 The amygdala has been shown to have an association with the olfactory system. 
The amygdala receives olfactory information through a number of pathways (Pitkanen, 
2000; Shipley, McLean, & Ennis, 1995). The amygdala’s medial nucleus receives 
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extensive input from the main and accessory olfactory systems, however, the lateral, 
basal, and central nuclei do not receive any direct input from the olfactory system. 
Conversely, the accessory basal nucleus receives significant input from the olfactory 
system, and projects directly to the lateral nucleus of the amygdala (McDonald, 1998; 
Savander, Go, LeDoux, & Pitkanen, 1996), therefore suggesting that the basolateral 
complex and the central nucleus fear circuit of the amygdala are able to participate in the 
fear expression of the olfactory system, especially olfactory fear conditioning (Otto, 
Cousens, & Herzog, 2000). Finally, the bed nucleus of the stria terminalis is not strictly 
part of the amygdala, but is thought to be an extension of the amygdala (Alheid, de 
Olmos, & Beltramino, 1995). The bed nucleus of the stria terminalis has many reciprocal 
connections to the amygdala and is thought to play a role in unconditioned fear 
behaviour.          
  
1.8 The Fear Circuitry of the Acoustic Startle Response 
  
 The neuronal basis of the fear potentiated ASR has been intensely researched by 
many groups which have provided a relatively complete picture of the fear circuitry 
involved. Research involving lesions and drug infusions of the amygdala has identified 
the amygdala as an important structure in the sensitizing effects of electric footshock 
(Fendt et al., 1994; Davis, 1992; Sananes & Davis, 1992; Schanbacher, Koch, Pilz, & 
Schnitzler, 1996). The startling stimulus, such as a loud noise is aversive and produces a 
state of fear or anxiety in the subject. The amygdala has been proposed to control and 
activate the startle reflex. The circuitry identified in sensitization of the ASR by 
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footshock is thought to begin at the PnC, which projects from the medial central 
amygdaloid nucleus via the caudal division of the ventral amygdalofungal pathway to the 
PnC (Koch, 1999; Davis et al., 1993; Campeau & Davis, 1995).  
  
 When the central nucleus or basolateral amygdala is lesioned, fear in the ASR is 
blocked (Davis et al., 1993). It has been suggested that the association between neutral 
and aversive stimuli takes place in the lateral/basolateral nuclei of the amygdala 
(Campeau & Davis, 1995). The perirhinal cortex relays the visual or auditory CS 
information to the amygdala. Infusion of NMDA antagonists such as DL-2-amino-
5phosphonopentanoic acid (AP-5) into the basolateral amygdala has been shown to block 
fear acquisition, proposing the view that NMDA receptors are involved in the process of 
association between neutral and aversive stimuli in the amygdala (Campeau, 
Miserendino, & Davis, 1992; Gewirtz & Davis, 1997). It has been proposed that the fear 
potentiated ASR circuit receives its fearful input from the PnC (Davis et al., 2003). 
Research carried out by Davis and his colleagues (1993) found that when the amygdala is 
lesioned, the fear-potentiated startle response is blocked, suggesting that the pathway 
from the amygdala and PNC is also damaged. It was also discovered that the amygdala – 
PNC pathway is crucial for the reinstatement of fear after Pavlovian conditioning (Fendt 
et al., 1999).  
  
 Research has revealed that the amygdaloid pathway may distribute glutamate 
and/or corticotrophin- releasing hormones (CRH). Results demonstrated that infusions of 
AP5 and x-helical CRH (a CRH antagonist) into the PnC resulted in blocking the fear 
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potentiated ASR (Fendt, Koch, & Schnitzler, 1996; 1997). Infusions of the glutamate 
receptor antagonists 6-cyano-7nitroquinoxaline-2, and 3-dione (CNQX) into the 
amygdala have also demonstrated blocked expression of conditioned fear; indicating that 
the intra-amygdaloid projections are activated by the CS, using glutamate receptor 
actions (Kim & Davis, 1993).  The dopaminergic projection from the VTA to the 
amygdala has also been identified as playing a role in the expression of the fear 
potentiated ASR (Borowski & Kokkinidis, 1996; Lamont & Kokkinidis, 1998).   
  
 Infusions of CRH into the lateral ventricle, PnC, or infusion of cholecystokinin 
(CCK), Substance P (SP) into the PnC or amygdala have been shown to have enhancing 
effects on sentisitization. This indicates that these peptides are involved in sensitization. 
In contrast, research has shown sensitization can be blocked by infusion of SP antagonists 
into the PnC, or χ2 – adrenergic agonist ST – 91 into the amygdala. It has been observed 
that the enhancement of ASR by electric foot shock, bright illumination, or neuropeptide 
agonists outlasts the duration of the aversive stimulus. In contrast, the ASR in the fear 
potentiated startle is only enhanced momentarily when the aversive stimulus (CS) is 
presented suggesting that two different neuronal or neurochemical factors contribute to 
the potentiation of the ASR phenomenon. It has recently been put forward that the fear-
potentiated ASR reflects a rapid conditioned response to a fear provoking stimulus but 
does not provide an ideal model for various states of anxiety in humans (Koch, 1999). 
Anxiety is not brought upon by certain specific stimuli, rather it is a state of discomfort 
and apprehension. Distinctions can be made between conditioned (fear) and 
unconditioned (anxiety) forms of ASR enhancement. For example, the anxiety disorder 
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post-traumatic stress disorder (PTSD) is generally caused by an explicit traumatic 
experience that is similar to that of fear conditioning. The brain structures that mediate 
conditioned and unconditioned forms of aversive fear learning have considerable overlap, 
but also have some differences in the brain mechanisms involved (Koch, 1999). 
  
 The hippocampus has also been identified as playing a role in the enhancement of 
the ASR by CRH, but not in the fear potentiation of the ASR. The amygdala is necessary 
for both the sensitization of the acoustic startle reflex and fear potentiation of the ASR by 
bright illumination, not in enhancement of ASR by CRH. Areas predicted to be involved 
in enhancement of the ASR are the direct projections of the bed nucleus of the stria 
terminalis that projects to the PnC, but also the indirect route of the bed nucleus of the 
stria terminalis to the PnC via the amygdala. Other nuclei between the central amydala 
and PnC have also been implicated in contributing to sensitization. These are the 
periacqueductal gray, the laterodorsal tegmental nucleus, and the mesencephalic nuclei 
(Koch, 1999; Davis et al., 1993).  
 
1.9 The Role of the Hippocampus in Fear 
 
Considerable research has concentrated on how the fear conditioning circuitry of 
the amygdala fits in with other larger brain regions. The brain is thought to have two 
different learning systems to perform the function of rapidly learning novel information 
and acquiring information about one’s environment. Therefore, much research has 
concentrated on the functions of the hippocampus and posterior neo-cortex (McClelland, 
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McNaughton, & O’Reilly, 1995; Norman & O’Reilly, 2003; O’Reilly & McClelland, 
1994; O’Reilly & Rudy, 2001). It was Scoville and Milner’s (1957) investigation into 
bilateral resection of the medial temporal lobe that was shown to cause anterograde 
amnesia in humans. This resulted in a sudden interest in the neuropsychology of memory 
(Milner, Squire, & Kandel, 1998). The focus of many studies was the hippocampus and 
the most famous patient was H.M. who had substantial bilateral damage to the 
hippocampus (Corkin, Amaral, Gonzalez, Johnson, & Hyman, 1997; Scoville & Milner, 
1957).  
 
Many animal studies were carried out in order to determine the role of the 
hippocampus in amnesia. These studies were carried out until the 1960s and revealed that 
animals with large hippocampal lesions were still able to learn a variety of new tasks. The 
abnormalities that were highlighted were not in new task acquisition, but instead a 
tendency to persist in the learned responses once they were no longer appropriate 
(Bannerman, Rawlins, McHugh, Deacon, Yee, Bast, Zhang, Pothuizen, & Feldon, 2004). 
There was also evidence of preservative responding during extinction (Jarrard & 
Isaacson, 1965), difficulty in reversal learning (Kimble & Kimble, 1965), and excessive 
responding in operant schedules (Clark & Isaacson, 1965). These observations and results 
led to the formulation of hippocampal theories and investigation into the role that the 
hippocampus may play in behavioural inhibition (Bannerman et al., 2004).  
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Researchers have agreed that the major function of the hippocampus is to encode 
episodic and spatial memories (Squire, 1992; Vargha-Khadem, Gadian, Watkins, 
Connelly, Van Paesschen, & Mishkin, 1997). It has also been suggested that the 
hippocampus plays an important function in learning and forming memories. Human 
amnesia is commonly associated with damage to the medial temporal lobe, and it is 
postulated that the hippocampus is critically involved in severe declarative memory 
deficits. Spatial memory deficits in rodents are thought to model some aspects of episodic 
memory deficits in human amnesics. Research on rodents with hippocampal lesions have 
demonstrated memory deficits in maze tasks, which suggests that the hippocampus in 
rodents is important for spatial learning and memory (Bannerman, Grubb, Deacon, Yee, 
Felden, & Rawlins, 2003).  
 
Recently, it has been revealed that the hippocampus is not only involved in 
forming memories, but also plays a general role in information processing and the 
successive regulation of behaviour. Bannerman and his colleagues (2004) recently 
described and defined the specific regions of the hippocampus. The dorsal hippocampus 
was identified as 50% of the subregion of the hippocampus volume, beginning at the 
septal pole (posterior hippocampus) and being primarily involved in spatial learning and 
memory (Bannerman, Grubb, Deacon, Yee, Feldon, & Rawlins, 2002). The ventral 
hippocampus subregion was defined as 50% of the hippocampus volume beginning at the 
anterior hippocampus, and being primarily concerned with anxiety-related behaviours. 
The ventral hippocampus has also been recently implicated in emotional processes that 
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are different to the amygdala, but is suggested to be associated with fear rather than 
anxiety (Bannerman et al., 2004).  
  
1.10 The Various Functions of the Dorsal Hippocampus   
  
 Research has shown that the major input to the dorsal hippocampus is visuo-
spatial information from primary sensory cortical areas projected via the association 
cortex, and the peririhinal and entorhinal areas (Amaral & Witter, 1995; Burwell & 
Amaral, 1998a; Burwell & Amaralb, 1998b; Dolorfo & Amaral, 1998a; Dolorfo & 
Amaral, 1998b). Other sensory input such as the olfactory input tends to be evenly 
distributed across the dorsoventral hippocampus (Moser & Moser, 1998). Research 
investigating different subregions of the hippocampus has revealed that lesions of these 
various areas have quite varying and distinct behavioural effects. Early behavioural 
experiments (Hughes, 1965; Nadel, 1968; Stevens & Cowey, 1973; Sinnamon, Feniere, 
& Kootz, 1978) and anatomical studies of the hippocampus (Siegel & Tassoni, 1971, 
Swanson & Cowan, 1977; Witter, 1986) have demonstrated a difference in the roles 
played between the dorsal and ventral hippocampus.  
  
 Moser and his colleagues (Moser, Moser, & Andersen, 1993) demonstrated that 
lesions to the dorsal hippocampus severely disrupted spatial learning in a Morris 
watermaze, resembling complete hippocampal lesions, while lesions to the ventral 
hippocampus showed no such effect. These results were later replicated again by Moser 
and his colleagues using ibotenic acid lesions instead of aspiration lesions (Moser, Moser, 
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Forrest, Andersen, & Morris, 1995). Results demonstrated that spatial learning was in 
tact, but animals still displayed impairment in the watermaze task, with only 26% of the 
dorsal hippocampus still remaining, and 60% of the ventral hippocampus still in tact. The 
use of ibotenic acid lesions resulted in having discrete and specific lesions to the intended 
areas as well as having the effect of preserving nerve fibers and cerebrovasculature 
passing via the lesioned area (Jarrard, 1989).  
  
 Moser’s (Moser et al., 1993; Moser et al., 1995) results add to the view that 
different subregions of the hippocampus tend to be involved in various functions of the 
brain. A number of studies have also examined the various effects of dorsal and ventral 
hippocampal cytotoxic lesions on spatial learning using a variety of learning paradigms 
and have revealed similar results to that of Moser (Moser et al., 1993; Moser et al., 1995; 
Bannerman, et al., 2002; Bannerman, Yee, Good, Heupel, Iversen, & Rawlins, 1999; 
Kjelstrup, Tuvnes, Steffenach, Murison, Moser, & Moser, 2002; McHugh, Deacon, 
Rawlins, & Bannerman, 2004). The results of these studies have demonstrated 
impairment in spatial reference memory acquisition in the watermaze task and T-Maze 
tasks, (Bannerman, et al., 2002; Hock & Bunsey, 1998), and performance on the radial 
maze (Pothuizen, Zhang, Jongen-Relo, Feldon, & Yee, 2004) after receiving dorsal 
hippocampal lesioning, therefore demonstrating similar results as complete hippocampal 
lesions. In contrast, lesioning of the ventral hippocampus did not impair performance of 
the above tasks.  
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 The difference found between the dorsal and ventral hippocampus in spatial 
learning may be less conclusive than it is conveyed, instead the ventral hippocampus may 
contribute to spatial learning under certain conditions (De Hoz, Knox, & Morris, 2003; 
Ferbinteanu & McDonald, 2000; Ferbinteanu, Ray, & McDonald, 2003). De Hoz and 
colleagues (2003) have demonstrated that rats with excitotoxic dorsal hippocampal 
lesions were able to acquire a spatial reference memory task after training in a Morris 
watermaze. Animals with complete hippocampal lesions did not show this improvement 
in performance, the results of the experiment suggest that under certain conditions the 
ventral hippocampus is able to contribute to spatial learning. These results support the 
view that there are anatomical differences along the septotemporal axis of the 
hippocampus suggesting extensive connectivity between the dorsal and ventral 
hippocampus, as well as having some functional interindependence between the two 
subregions (Amaral & Witter, 1989; Amaral & Witter, 1995).  
 
1.11 The Various Functions of the Ventral Hippocampus  
  
 The ventral hippocampus subregion is quite different from its dorsal counterpart 
in its anatomical connections. The ventral hippocampus projects to the prefrontal cortex, 
while the dorsal hippocampus does not (Barbas & Blatt, 1995; Goldman-Rakic, Selemon, 
& Schwartz, 1984; Jay & Witter, 1991; Verwer, Meijer, Van Uum, & Witter, 1997). The 
ventral hippocampus is connected to the bed nucleus of the stria terminalis (BNST) and 
the amygdala (Henke, 1990; Krettek & Price, 1977; Petrovich, Canteras, & Swanson, 
2001; Pitkänen, Pikkarainen, Nurminen, & Ylinen, 2000; Swanson & Cowan, 1977; Van 
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Groen & Wyss 1990), and also to other subcortical structures associated with the 
hypothalamic-pituitary-adrenal (HPA) axis (Amaral & Witter, 1995; Siegel & Tassoni, 
1971;  Swanson & Cowan, 1977; Witter, 1986). Many of the amygdala nuclei have 
reciprocal projections with the hippocampus, mainly affiliated with the basal and lateral 
nuclei (Pitkänen et al., 2000). The evidence of strong connectivity between the ventral 
hippocampus, hypothalamus, and amygdala suggests a possible role for the ventral 
hippocampus in fear and/or anxiety, therefore accounting for some evidence 
demonstrating the relationship between ventral hippocampal lesions and inhibited 
emotional responses. The most extensively studied paradigm is contextually conditioned 
freezing.  
  
 Freezing in rats is a fear response that immobilises the animal after fear 
conditioning. The rat associates an unconditioned aversive stimulus, such as footshock, 
with a conditioned stimulus and expresses their fear in the situation where escape is not 
possible (Fanselow, 1984). Many studies have demonstrated that hippocampal lesions 
both disrupt the acquisition and expression of contextual fear conditioning (Good & 
Honey, 1997; McNish, Gewirtz, & Davis, 1997). Some research has shown over recent 
years that the ventral hippocampus shows similar results to complete hippocampal 
damage in reducing the fear response of freezing after receiving a mild form of footshock 
(Richmond, Yee, Pouzet, Veenman, Rawlins, Feldon, & Bannerman, 1999; Kjelstrup et 
al., 2002). The reduction of freezing was demonstrated for both conditioning to a tone 
and a context where shock had already been delivered previously during the training 
stage. A similar decrease in freezing was also shown after ventral subiculum lesions 
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(Maren, 1999). In contrast, Richardson and his colleagues (Richmond et al., 1999) 
demonstrated that dorsal hippocapal lesions did not have any type of effect on freezing 
(Maren, Aharonov, & Fanselow, 1997).  
  
 The results of the various experiments suggest that the ventral hippocampus tends 
to be involved in conditioned freezing unlike its dorsal neighbour. However, these 
conclusions are still under debate and must be treated with some caution (Anagnostaras, 
Gale, & Fanselow, 2001; Anagnostaras, Gale, Fanselow, 2002, Bast, Zhang, & Feldon, 
2001; Bast, Zhang, & Feldon, 2003; Kjelstrup et al., 2002). For instance, conditioned 
freezing may not be the best paradigm used for investigating the relationship between the 
dorsal and ventral hippocampus in anxiety-related behaviours, it is vitally important to 
explore other paradigms. Alternative approaches to the conditioned freezing paradigm is 
the use of pharmaceuticals to temporarily manipulate areas in the brain with intracerebral 
drug infusions. Many drug infusion experiments into the ventral and dorsal hippocampus 
have revealed that they both play a role in memory processing in conditioned fear 
responses (Anagnostaras et al., 2001; Anagnostaras et al., 2002, Bast et al., 2001; Bast et 
al., 2003; Sanders, Wiltgen, & Fanselow, 2003).  
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1.12 Role of ventral hippocampus and amygala in anxiety-related processes 
 
 Experiments investigating the effects of amygdaloid and ventral hippocampal 
lesions have revealed that they both contribute differently to the processing of fearful or 
anxiety provoking stimuli (Iwata, LeDoux, Meeley, Arneric, & Reis, 1986; Phillips & 
LeDoux, 1992; Richmond et al., 1999). This view is not a novel account (Gray & 
McNaughton, 2000) as research has shown that fear and anxiety are related to one 
another as it has been suggested that they should be thought of as a unitary construct 
(Davis & Shi, 1999; Gray & McNaughton, 2000; Ramos, Berton, Mormede, & 
Chaouloff, 1997). Davis and his colleagues state that fear is a phasic response to 
conditioned aversive cues, while anxiety is a tonic and unconditioned response to an 
aversive cue or situation (Davis & Shi, 1999). Gray and McNaughton (2000) have a 
similar view stating that fear is an avoidant or escape response (phasic) where the subject 
must escape a possible dangerous situation in order to survive. Anxiety arises from 
conflict or uncertainity and is a result of diffuse aversive stimuli: for example, a subject 
wonders whether it should enter or approach a dangerous situation. It is also proposed 
that fear is a pre-cursor of anxiety and that anxiety serves as an inhibitory fear response.     
   
 Research using the fear potentiated startle response have shown some supporting 
evidence for the separate roles that the hippocampus and amygdala play in fear and 
anxiety related behaviours. As the ASR is elicited by a sudden auditory stimulus that 
results in the skeletal muscles rapidly contracting, it has been assumed to be an 
unconditioned response to fearful stimuli. The potentiated startle reflex is mediated by 
the brain stem circuit (Davis, Gendelman, Tischler, & Gendelman, 1982; Yeomans & 
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Frankland , 1996) and modulated by the forebrain areas (Koch, 1999). The bed nucleus of 
the stria terminalis (BNST) and the amygdala are closely connected to the ventral 
hippocampus (Pitkänen et al., 2000; Swanson & Cowan, 1977) which access and control 
the startle circuit (Davis & Shi, 1999; Koch, 1999). Emotional responses have been 
shown to influence startle reactivity (Koch, 1999; Lang, 1995). In fact the enhancement 
of the startle reflex is a diagnostic criterion for human anxiety disorders and is also 
employed in animal models of fear and anxiety (Davis & Shi, 1999; Rodgers, 1997). The 
startle reflex is a protective response to an aversive or threatening stimulus and is able to 
be enhanced by negative emotional states, or attenuated by positive emotional states 
(Lang, 1995). In the fear potentiated conditioning paradigm rats are first taught to be 
fearful of the light (CS) that predicts the following footshock (UCS). The conditioned 
fear to the light is then measured by the startle response of the animal when the light is 
presented in the experimental chamber absent of the footshock. It has been shown by 
many studies that the fear-potentiated startle response can be blocked by lesions of the 
amygdala (Davis, 1992, Davis et al., 1982; Davis & Shi, 1999). However, lesions of the 
hippocampus have not been able to show reliable affects of the startle magnitude (Bast et 
al., 2003; Kemble & Ison, 1971; Leaton, 1981; Lee & Davis, 1997a; Lee & Davis, 1997b; 
Pouzet, Feldon, Veenman, Yee, Richmond, Nicholas, Rawlins, & Weiner, 1999). 
Microinfusions of a variety of drugs such as NMDA agonists or antagonists, tetrodotoxin, 
muscimol, and picrotoxin into the dorsal and ventral hippocampus have tended to 
attenuate the startle response (Bast et al., 2001; Bast et al., 2003; Wan, Caine, & 
Swerdlow, 1996; Zhang, Bast, & Feldon, 2000; Zhang, Bast, & Feldon, 2002). In 
contrast, the NMDA receptor antagonist MK-801 tended to show a potentiated basal 
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startle response when infused into the dorsal hippocampal region (Zhang, Bast, & Feldon, 
2000). Therefore, no specific hippocampal role has been identified in the fear potentiated 
startle response.  
  
 A very different picture is beginning to emerge when the startle response is 
elicited by an anxious state, induced by intracerebroventricular (i.c.v) microinfusions of 
CRH. CRH infusions tend to elicit a response that resembles that of anxiety or stress 
(Dunn & Berridge, 1990). This is displayed through physiological, endocrinological, and 
behavioural changes which include an increase in the startle amplitude. Increasing 
evidence has shown that the hippocampus and its connectivity with the BNST represent a 
neural circuit that is intrinsic to the enhancement of the CRH startle. Research by Lee and 
Davis (1997a; 1997b) has been able to demonstrate that the primary action of CRH is 
most likely to be the BNST. However, cytotoxic lesions of the BNST completely block 
the CRH-enhanced startle response, but they did not show any effect on the acquisition of 
classical fear-potentiaed startle response to an explicit visual CS. In contrast, cytotoxic 
lesions of the central and basolateral nuclei of the amygdala have been shown to block 
the fear potentiated startle reflex, but have no effect on the CRH-enhanced startle. 
Therefore, this dissociation between the BNST and the amygdala lesions of the fear 
potentiated startle paradigm demonstrate and further lend support to the view that there 
are various components involved in the emotional states of fear and anxiety, with diverse 
underlying neural substrates. The research carried out by Lee and Davis (1997a; 1997b) 
is still unclear, however it does suggest that the ventral hippocampus may have 
projections to the BNST, which may be an important neural pathway that influences the 
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various states of anxiety (Amaral & Witter, 1995; Canteras & Swanson, 1992; Cullinan, 
Herman, & Watson, 1993; Swanson & Cowan, 1977) and that is different to the neural 
fear circuit of the amygdala. 
  
1.13 The Present Study Summary 
 
 When a human or animal is threatened or confronted with danger, internal 
defence mechanisms are activated that evoke feelings of fear and anxiety. These feelings 
promote the behaviour patterns necessary for an organism’s survival. Animal research 
seeks to understand how these emotions affect behaviour both physiologically and 
neurologically in order to develop effective treatment for those suffering from severe 
anxiety disorders (Fendt & Fanselow, 1999). Our research will attempt to understand the 
neural basis of fear and anxiety in rodents. This was carried out by modelling fear in 
laboratory rats using the fear-potentiated startle paradigm. The amygdala has been 
identified as playing a key role in fear learning in a variety of experiments and research. 
It has been demonstrated that damage or interference to this area causes a disruption in 
neurotransmission and conditioning effects. The purpose of this thesis is to examine the 
role of the amygdala, and dorsal and ventral hippocampus in relation to immediate fear 
arousal brought on by footshock. This was assessed by examining whether muscimol will 
interfere with the ASR before or after footshock presentation, and then comparing these 
reactions to a control group that receive saline infusions. The results of this research are 
extremely important because they identify various brain structures involved in the fear-
arousing effects of footshock. We expected that the agonistic action of gamma – 
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aminobututyric acid A receptors (GABA A) produced by muscimol in the amygdala 
would block the shock-associated fear. However, the key question was whether or not 
other forebrain structures, like the dorsal and ventral hippocampus that are connected to 
the amygdala and also contribute to fear arousal. 
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2.0  METHOD 
 
2.1  Subjects 
 
Approximately 70 naïve male albino rats of the Wistar strain were used for the 
experiments. There were nine groups of rats with 7-8 subjects per group. 48 received 
varying doses of 0.1ug and 0.01ug of the drug muscimol (experimental group) and the 
other 22 (control group) received saline. The rats were bred in the University of 
Canterbury’s Psychology laboratory and were held in a climatically controlled colony 
environment, in grouped-housing with free access to food and water. The subjects 
weighed approximately 300-350g when used.  
 
2.2  Apparatus 
  
 The acoustic startle reflex amplitudes and footshock delivery were measured in 
four identical cages (16.5cm x 8cm x 9cm), which were located inside sound attenuating 
melamine chambers (60cm x 34cm x 56cm). The sides and lid of each startle cage (Med 
Associates, Fairfield, VT) were manufactured from stainless steel horizontal rods 0.25cm 
in diameter and were situated 1.5cm apart. The floor of the startle cage consisted of 
stainless steel rods, with a 0.45cm diameter. A metal frame 10cm away from each cage 
housed a 6.0cm speaker. The startle cages were mounted on a Med Associates load cell-
based startle platform (25cm x 11.5cm x 4.5cm). Movement amplitude were rectified, 
digitised, and recorded by Med Associates software which controlled the white noise and 
scrambled shock stimuli. The acoustic stimulus was produced by a programmable audio 
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generator which consisted of a 100-ms white noise burst with a rise-decay time of 10ms. 
The ambient noise level in the chambers were 36dB as measured by a Bruel & Kjaer 
(Model 2235; Denmark) sound level meter (A Scale). The 600-µA footshock was 
delivered through the floor grid by constant current stimulators connected to 
commutators located on top of each sound attenuating chamber with stimulation leads 
attached to each startle cage. 
 
2.3  Surgery 
  
 Surgery was performed in accordance with protocols approved by the Animal 
Ethics Committee at the University of Canterbury. Subjects first received atropine 
sulphate (0.12mg/kg) prior to anaesthesia in order to dry-up mucous secretions. Twenty 
minutes later they were then anaesthetised with sodium pentobarbitone (90mg/kg) and 
put in a Stoelting stereotaxic instrument (WoodDale, IL). Subjects received a 
mepivacaine (local anaesthetic) scalp injection (20mg/ml) before surgery and an anti-
inflammatory local injection of ketofen (10mg/ml) prior to suturing (as required by the 
ethical guidelines). The horizontal plane of each subject’s skull was levelled using the 
landmarks Bregma (anterior) and Lamda (posterior). Stereotaxic co-ordinates were 
calculated by using the stereotaxic atlas of the rat brain by Paxinos and Watson (1998). 
Stainless Steel guide cannulas (C313G, Plastics One, Roanoke, VA) were implanted 
bilaterally with an outer diameter of 0.71mm. The co-ordinates for bilateral implants into 
the amygdala were AP - 2.8, ML ± 4.8 and DV – 8.2, ventral hippocampus AP -5.6 ML ± 
4.6 DV – 6.4 and dorsal hippocampus AP – 5.6 ML ±3.6  DV – 3.0. The implants were 
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fixed to the skull using dental cement and 4 stainless steel jeweller’s screws (Lomat, 
Quebec, Canada). Subjects were left to recover for approximately 7 days before 
commencement of testing. 
 
2.4  Procedure 
 
2.4.1 Baseline Acoustic Startle (Pre-drug) 
 
The procedure of the proposed experiment was approved by the Animal Ethics 
Committee of the University of Canterbury. Seven days post-surgery each subject’s 
acoustic startle threshold was measured. The rat were first placed into the startle 
apparatus and given a 5-minute period of acclimatisation. They then received 2 sessions 
of 30 white noise bursts with a fixed interval of 20 seconds between each noise burst. The 
decibel level of the white noise bursts were alternated between 91, 95 and 99dB in 
intensity. For each subject, the noise level that produced an average startle amplitude 
between 100 and 400 units was selected and used for all subsequent testing. 
 
2.4.2 Drug Infusion and Acoustic Startle Testing 
 
The day after baselining the rats were returned to the startle apparatus and given 
another session of 20 noise bursts with a 30second interval between noise bursts at the 
pre-selected decibel level. The subject was then taken out of the box and infused with the 
drug muscimol (0.1µg/µlor 0.01µg/µl) or saline. The dummy cannulas were then 
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removed (C313DC, Plastics One) and 28-gauge (0.36mm) stainless steel infusion needles 
(C313I, Plastics One) were then inserted into each cannula. Polyethylene tubing (PE20, 
Plastics One) was pre-loaded with either muscimol or saline and attached to each cannula 
implant of the subject. The polyethylene tubing was attached to a 2-µl Hamilton syringe 
and infused over a 1 minute period at a volume of 0.5 µl per side with infusion pumps 
(Model 310, Stoelting). After infusion stopped, the needles were left for a further 2 
minutes, and then removed and replaced with dummy cannulas. The subject was then 
returned to the startle apparatus and again put through a post-drug test. The test consisted 
of a 1 minute acclimatisation period, followed by a session of 20 noise bursts with a fixed 
interval of 30 seconds, then a session of 10 unsignalled footshocks with 10 second 
intervals, and lastly a session of 10 noise bursts with a fixed interval of 30 seconds. 
 
2.5 Perfusion and Histology 
  
 70 subjects with bi-cannula implants into the amygdala, dorsal hippocampus and 
ventral hippocampus were culled and then perfused intracardially with saline, followed 
by a 10% formalin solution. The brains were removed quickly and stored in the formalin 
solution for one-day, and then transferred to a sucrose solution and refrigerated. The 
subjects’ brains were then sliced (50µm) after 2-3weeks storage using a cryostat and were 
then mounted onto gel coated slides. The slides were then stained with cresyl violet and 
later evaluated using a microscope and the stereotaxic atlas of the rat brain by Paxinos 
and Watson (1998) so that the guide cannula placements could be verified. 
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3.0 RESULTS 
 
3.1 Amygdala 
 
3.1.1 Histology 
  
 Two rats in the amygdala group were excluded from the study after developing 
loose acrylic headcaps. The guide cannula locations in the basolateral amygdala for the 
remaining rats in the group (Saline N = 7, Muscimol 0.1ug N = 8, Muscimol 0.01ug N = 
8) are depicted in Figure 1. In all 16 of the cannulated experimental rats, the centres of 
the infusion sites (the tips of the infusion cannulae) were located in the targeted areas 
within or around the border of the BLA. Guide cannula placements were implanted and 
aimed 1mm above the BLA (co-ordinates AP – 2.8mm from bregma, ML ± 4.8mm from 
the sagital suture, DV- 8.2mm from the skull surface). Visible tissue damage was 
restricted to the immediate surrounding area of the guide and infusion cannulae.  
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Figure 1. A schematic representation of the guide cannula locations for the Saline (N = 7), 
Muscimol 0.1ug (N = 8), and Muscimol 0.01ug (N = 8) infusion groups. Guide cannula 
placements were implanted and aimed 1mm above the Basolateral Amygdala (co-ordinates AP – 
2.8mm from bregma, ML ± 4.8mm from the sagital suture, DV- 8.2mm from the skull surface). 
The representative sections (-2.30mm - -2.80mm from bregma) were taken from The Rat Brain in 
Stereotaxic Coordinates, by Paxinos and Watson (1998).    
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3.12 Acoustic Startle and Selected Decibel Levels 
  
 The acoustic startle levels of the individual animals did not differ significantly 
across the saline and amygdala groups during the baseline screening session, F (1,21) = 
0.72, p = 0.41, ns. Therefore, any differences seen in the startle levels of the animals post 
sensitization were not a result of variable baseline levels. The decibel levels selected for 
each subject also did not differ significantly between the saline and muscimol groups, F = 
(1,21) = 0.29, p = 0.60, ns. The noise burst decibel level varied between 91 – 99 dB, with 
an average of 94.30 dB.    
 
3.13 Effects of Muscimol Drug Infusion into the BLA for Shock Sensitization   
  
 In this experiment subjects firstly received a baseline session of 20 white noise 
bursts, followed quickly by the infusion of muscimol 0.1ug, 0.01ug, or saline, and were 
then placed back into the experimental chamber for the sensitization experiment of 20 
white noise bursts, 10 footshock, and lastly 20 white noise bursts. The behavioural data is 
shown in Figure 2. Subjects that received intracranial infusions of saline served as a 
control group (N=7) for the animals that received intracranial infusions of muscimol 
0.1ug or 0.01ug prior to the sensitization session. A repeated measures ANOVA of the 
acoustic startle data for the muscimol drug group 0.1ug revealed main effects of startle 
session, F(2,26) = 11.35, p < 0.0003 and a significant drug treatment x startle session 
interaction F(2,26) = 12.75, p < 0.0001. A repeated measures ANOVA of the acoustic 
startle data for the muscimol drug group 0.01ug revealed main effects of startle session, 
F(2,26) = 17.57, p < 0.00002 and a significant drug treatment x startle session interaction 
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F(2,26) = 7.86, p < 0.002. Figure 2 depicts that intra BLA muscimol infusion did not 
significantly affect acoustic startle amplitudes baseline versus postdrug. A Bonferroni 
post-hoc analysis revealed that both doses of muscimol (0.1ug and 0.01ug) infused into 
the BLA blocked the shock sensitization of the acoustic startle response (see figure 2). 
Therefore, muscimol infusion into the BLA blocked the fear potentiating effects of 
footshock on the amplitude of the acoustic startle response. A one-way ANOVA of the 
difference scores (post shock – post drug acoustic startle scores) was carried out between 
the muscimol 0.1ug and 0.01ug (experimental) and saline (control) groups (see figure 3). 
A one way ANOVA of the difference scores revealed a significant main effect for drug 
treatment F(1,13) = 15.02, p<0.0019 (muscimol 0.1ug vs. saline),  and F(1,12) = 8.08, 
p<0.014 (muscimol 0.01ug vs. saline) represented in Figure 3. The results revealed that 
infusions of muscimol 0.1ug and 0.01ug into the BLA significantly inhibited the shock-
enhanced acoustic startle amplitudes of the subjects. A Bonferroni post-hoc analysis 
confirmed that the two varying doses of muscimol used in the current study significantly 
inhibited sensitization relative to the saline-treated control group. Therefore, the subjects 
in the two varying drug groups failed to demonstrate sensitization after receiving intra-
BLA drug infusions of muscimol in comparison to the control group.   
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Figure 2. Mean (±S.E.M.) acoustic startle amplitude as a function of test session 
(baseline, postdrug infusion, and postshock) following intraBLA infusion of saline (N=7) 
or muscimol 0.1ug (N=8), 0.01ug (N=8) (*p < 0.01). 
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Figure 3. Mean difference score (post shock – post drug) following infusion of saline 
(N=7) or muscimol 0.1ug (N=8), 0.01ug (N=8) into the BLA.   
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3.14 Shock Reactivity 
 
 In order to demonstrate that drug infusions did not significantly attenuate the 
shock reactivity of the subjects a one-way ANOVA was used. There was no significant 
difference in shock reactivity between the muscimol drug group and the saline group,  
F(1,21) = 3.10, p<0.09, ns. Therefore, the anxiolytic actions of muscimol infused into the 
BLA cannot be effected by possible drug effects on sensorimotor responding as a 
suppression of movement amplitude was not induced by the muscimol infusion (see 
Figure 4).  
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Figure 4. Mean movement amplitude recorded 100ms before shock and 100ms after 
shock onset following infusion of Saline (N = 7), Muscimol 0.1ug (N = 8), or Muscimol 
0.01ug (N = 8) into the BLA. ANOVA did not reveal any significant difference between 
the groups. 
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3.2 Dorsal Hippocampus 
 
3.2.1 Histology 
  
 One rat in the dorsal hippocampus group was excluded from the study after 
developing a loose acrylic headcap. The guide cannula locations in the dorsal 
hippocampus for the remaining rats in the group (saline N = 7, muscimol 0.1ug N = 8, 
muscimol 0.01ug N = 8) are depicted in Figure 5. In all 16 of the cannulated experimental 
rats, the centres of the infusion sites (the tips of the infusion cannulae) were located in the 
targeted areas within or around the border of the ventral hippocampus. Guide cannula 
placements were implanted and aimed 1mm above the ventral hippocampus (co-ordinates 
AP –5.6mm from bregma, ML ±3.6 mm from the sagital suture, DV-3.0 mm from the 
skull surface). Visible tissue damage was restricted to the immediate surrounding area of 
the guide and infusion cannulae.  
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Figure 5. A schematic representation of the guide cannula locations for the Saline (N = 7), 
Muscimol 0.1ug (N = 8), and Muscimol 0.01ug (N = 8) infusion groups. Guide cannula 
placements were implanted and aimed 1mm above the Dorsal Hippocampus (co-ordinates AP – 
5.6mm from bregma, ML ± 3.6mm from the sagital suture, DV- 3.0mm from the skull surface). 
The representative sections (-4.52mm - -5.60mm from bregma) were taken from The Rat Brain in 
Stereotaxic Coordinates, by Paxinos and Watson (1998).    
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3.2.2 Acoustic Startle and Selected Decibel Levels 
  
 The acoustic startle levels of the individual animals did not differ significantly 
across the saline and dorsal hippocampus groups during the baseline screening session, F 
(1,21) = 0.35, p = 0.56, ns. Therefore, any differences seen in the post sensitization startle 
levels of the animals were not a result of variable baseline levels. The decibel levels 
selected for each subject also did not differ significantly between the saline and muscimol 
groups, F = (1,21) = 0.69, p = 0.41, ns. The noise burst decibel level varied between 91 – 
99 dB, with an average of 95.17 dB.    
 
3.2.3 Effects of Muscimol Drug Infusion into the Dorsal Hippocampus for Shock 
 Sensitization   
  
 In this experiment subjects firstly received a baseline session of 20 white noise 
bursts, followed quickly by the infusion of muscimol 0.1ug, 0.01ug, or saline, and were 
then placed back into the experimental chamber for the sensitization experiment of 20 
white noise bursts, 10 footshock, and lastly 20 white noise bursts. The behavioural data 
are shown in Figure 6. Subjects that received intracranial infusions of saline served as a 
control group (N=7) for the animals that received intracranial infusions of muscimol 
0.1ug or 0.01ug prior to the sensitization session. A repeated measures ANOVA of the 
acoustic startle data for the muscimol drug group 0.1ug revealed main effects of startle 
session, F(2,26) = 28.28, p < 0.000001 and a significant drug treatment x startle session 
interaction F(2,26) = 6.88, p < 0.0094 A repeated measures ANOVA of the acoustic 
startle data for the muscimol drug group 0.01ug revealed main effects of startle session, 
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F(2,26) = 43.88, p < 0.00001 and a significant drug treatment x startle session interaction 
F(2,26) = 5.32, p < 0.01. Figure 6 depicts that the intra dorsal hippocampus muscimol 
infusions did not significantly affect acoustic startle amplitudes (baseline versus 
postdrug). Bonferroni post-hoc analysis revealed that the 0.1ug muscimol dose infused 
into the dorsal hippocampus blocked the shock sensitization of the acoustic startle 
response (see figure 7). The 0.01ug dose of muscimol infused into the dorsal 
hippocampus showed a significant increase in startle amplitudes following drug 
infusions. Therefore, the muscimol infusion of 0.1ug into the dorsal hippocampus 
blocked the fear potentiating effects of footshock on the amplitude of the acoustic startle 
response. A one-way ANOVA of the difference scores (post shock – post drug acoustic 
startle scores) was carried out between the muscimol 0.1ug and 0.01ug (experimental) 
and saline (control) groups (see figure 7). ANOVA of the difference scores revealed a 
significant main effect for drug treatment F(1,13) = 8.65, p<0.01 (muscimol 0.1ug vs. 
Saline),  and F(1,13) = 7.50, p<0.02 (muscimol 0.01ug vs. saline) represented in Figure 7. 
The results reveal that infusions of muscimol 0.1ug and 0.01ug into the dorsal 
hippocampus significantly inhibited the shock-enhanced acoustic startle amplitudes of the 
subjects. Post-hoc analysis using the Bonferroni test confirmed that the two varying doses 
of muscimol used in the current study significantly inhibited sensitization relative to the 
saline-treated control group. Therefore, the subjects in the two varying drug groups failed 
to demonstrate sensitization after receiving intra-dorsal hippocampus drug infusions of 
muscimol in comparison to the control group. These results are similar to those reported 
earlier following intra BLA and ventral hippocampus infusions of muscimol.   
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Figure 6. Mean (±S.E.M.) acoustic startle amplitude as a function of test session 
(baseline, postdrug infusion, and postshock) following intra dorsal hippocampus 
infusions of saline (N=7) or muscimol 0.1ug (N=8), 0.01ug (N=8) (*p < 0.01). 
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Figure 7. Mean difference score (post shock – post drug) following infusion of saline 
(N=7) or muscimol 0.1ug (N=8), 0.01ug (N=8) into the dorsal hippocampus.   
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3.2.4 Shock Reactivity 
 
 In order to demonstrate that drug infusions did not significantly attenuate the 
shock reactivity of the subjects a one-way ANOVA was used. There was no significant 
difference in shock reactivity between the muscimol drug group and the saline group,  
F(1,21) = 0.97, p<0.34, ns. Therefore, the anxiolytic actions of muscimol infused into the 
dorsal hippocampus cannot be affected by possible drug effects on sensorimotor 
responding as a suppression of movement amplitude was not induced by the muscimol 
infusion (see Figure 8).  
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Figure 8. Mean movement amplitude recorded 100ms before shock and 100ms after 
shock onset following infusion of saline (N = 7), Muscimol 0.1ug (N = 8), or Muscimol 
0.01ug (N = 8) into the dorsal hippocampus. ANOVA did not reveal any significant 
difference between the groups. 
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3.3 Ventral Hippocampus 
 
3.3.1 Histology 
  
 Two rats in the ventral hippocampus group were excluded from the study after 
developing loose acrylic headcaps. The guide cannula locations in the ventral 
hippocampus for the remaining rats in the group (saline N = 8, muscimol 0.1ug N = 8, 
Muscimol 0.01ug N = 8) are depicted in Figure 9. In all 16 of the cannulated 
experimental rats, the centres of the infusion sites (the tips of the infusion cannulae) were 
located in the targeted areas within or around the border of the ventral hippocampus. 
Guide cannula placements were implanted and aimed 1mm above the ventral 
hippocampus (co-ordinates AP – 5.6mm from bregma, ML ± 4.6mm from the sagital 
suture, DV- 6.4mm from the skull surface). Visible tissue damage was restricted to the 
immediate surrounding area of the guide and infusion cannulae.  
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Figure 9. A schematic representation of the guide cannula locations for the Saline (N = 8), 
Muscimol 0.1ug (N = 8), and Muscimol 0.01ug (N = 8) infusion groups. Guide cannula 
placements were implanted and aimed 1mm above the Ventral Hippocampus (co-ordinates AP – 
5.6mm from bregma, ML ± 4.6mm from the sagital suture, DV- 6.4mm from the skull surface). 
The representative sections (-4.80mm - -6.04mm from bregma) were taken from The Rat Brain in 
Stereotaxic Coordinates, by Paxinos and Watson (1998).    
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3.3.2 Acoustic Startle and Selected Decibel Levels 
  
 The acoustic startle levels of the individual animals did not differ significantly 
across the saline and ventral hippocampus groups during the baseline screening session, F 
(1,21) = 1.37, p = 0.26, ns. Therefore, any differences seen in the startle levels of the 
animals post sensitization were not a result of variable baseline levels. The decibel levels 
selected for each subject also did not differ significantly between the Saline and 
muscimol groups, F = (1,22) = 0.13, p = 0.72, ns. The noise burst decibel level varied 
between 91 – 99 dB, with an average of 94.67 dB.    
 
3.3.3 Effects of Muscimol Drug Infusion into the Ventral Hippocampus for Shock 
 Sensitization   
  
 In this experiment subjects firstly experienced a baseline session of 20 white noise 
bursts, followed quickly by the infusion of muscimol 0.1ug, 0.01ug, or saline, and were 
then placed back into the experimental chamber for the sensitization experiment of 20 
white noise bursts, 10 footshock, and lastly 20 white noise bursts. The behavioural data 
are shown in Figure 10. Subjects that received intracranial infusions of saline served as a 
control group (N=8) for the animals that received intracranial infusions of muscimol 
0.1ug or 0.01ug prior to the sensitization session. A repeated measures ANOVA of the 
acoustic startle data for the muscimol drug group 0.1ug revealed main effects of startle 
session, F(2,28) = 22.89, p < 0.000001 and a significant drug treatment x startle session 
interaction F(2,28) = 5.56, p < 0.009. A repeated measures ANOVA of the acoustic 
startle data for the muscimol drug group 0.01ug revealed main effects of startle session, 
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F(2,28) = 15.77, p < 0.00003 and a significant drug treatment x startle session interaction 
F(2,28) = 6.06, p < 0.006. Figure 10 depicts that the intra ventral hippocampus muscimol 
infusion did not significantly affect acoustic startle amplitudes (baseline versus postdrug). 
Bonferroni post-hoc analysis revealed that both doses of muscimol (0.1ug and 0.01ug) 
infused into the ventral hippocampus blocked the shock sensitization of the acoustic 
startle response (see figure 11). Therefore, muscimol infusion into the ventral 
hippocampus blocked the fear potentiating effects of footshock on the amplitude of the 
acoustic startle response. A one-way ANOVA of the difference scores (post shock – post 
drug acoustic startle scores) was carried out between the muscimol 0.1ug and 0.01ug 
(experimental) and saline (control) groups (see figure 11). ANOVA of the difference 
scores revealed a significant main effect for drug treatment F(1,14) = 6.54, p<0.02 
(muscimol 0.1ug vs. saline),  and F(1,14) = 6.77, p<0.02 (muscimol 0.01ug vs. saline) 
represented in Figure 11. The results reveal that infusions of muscimol 0.1ug and 0.01ug 
into the ventral hippocampus significantly inhibited the shock-enhanced acoustic startle 
amplitudes of the subjects. Post-hoc analysis using the Bonferroni test confirmed that the 
two varying doses of muscimol used in the current study significantly inhibited 
sensitization relative to the saline-treated control group. Therefore, the subjects in the two 
varying drug groups failed to demonstrate sensitization after receiving intra-ventral 
hippocampus drug infusions of muscimol in comparison with the control group.   
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Figure 10. Mean (±S.E.M.) acoustic startle amplitude as a function of test session 
(baseline, postdrug infusion, and postshock) following intra ventral hippocampus 
infusions of saline (N=8) or muscimol 0.1ug (N=8), 0.01ug (N=8) (*p < 0.01). 
 54
Sa
lin
e
Mu
sc
im
ol 
0.1
ug
Mu
sc
im
ol 
0.0
1u
g
0
100
200
300
400
MEAN DIFFERENCE SCORES
for the
VENTRAL HIPPOCAMPUS
GROUPS
* *
DIFFERENCE SCORES
M
EA
N
 S
TA
R
TL
E 
A
M
PL
IT
U
D
E
 
Figure 11. Mean difference score (post shock – post drug) following infusion of saline 
(N=8) or muscimol 0.1ug (N=8), 0.01ug (N=8) into the ventral hippocampus.   
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3.3.4 Shock Reactivity  
  
 In order to demonstrate that drug infusions did not significantly attenuate the 
shock reactivity of the subjects a one-way ANOVA was used. There was no significant 
difference in shock reactivity between the muscimol drug group and the saline group,  
F(1,22) = 1.85, p<0.19, ns. Therefore, the anxiolytic actions of muscimol infused into the 
ventral hippocampus cannot be effected by possible drug effects on sensorimotor 
responding as a suppression of movement amplitude was not induced by the muscimol 
infusion (see Figure 12).  
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Figure 12. Mean movement amplitude recorded 100ms before shock and 100ms after 
shock onset following infusion of Saline (N = 8), Muscimol 0.1ug (N = 8), or Muscimol 
0.01ug (N = 8) into the ventral hippocampus. ANOVA did not reveal any significant 
difference between the groups. 
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4.0 DISCUSSION 
4.1 Main Findings 
  
 There was no significant effect of drug infusion on the acoustic startle levels 
(baseline vs postdrug) in the saline control animals and the muscimol drug groups for all 
three brain regions of the BLA, dorsal and ventral hippocampus. Therefore, the drug 
muscimol did not impair sensorimotor reflexes of the animals used in this study. This is 
important as the results demonstrate that the differences found in the startle levels of the 
animals post sensitization was not a result of variable baseline levels.  
 
4.2 Amygdala 
 
 Intra BLA infusions of the drug muscimol (GABA A receptor agonist) at 
measures of 0.1ug and 0.01ug significantly attenuated the shock sensitization of the 
acoustic startle response relative to the saline control animals. An ANOVA of the 
difference scores (post-shock – postdrug) confirmed the results of the repeated measures 
ANOVA in that the saline control group demonstrated significantly enhanced shock 
sensitization of the ASR in comparison with the 0.1ug and 0.01ug muscimol groups. An 
ANOVA of the shock reactivity between each group revealed no group differences in 
mean movement amplitudes (movement 100ms before and 100ms after receiving 
footshock). Therefore, the infusion of muscimol did not affect the animals’ ability to 
respond appropriately to the footshock, nor did it impair their ability to perceive the 
footshock as an aversive event.  
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4.3 Ventral Hippocampus 
  
 Intra ventral hippocampal infusions of the drug muscimol (GABA A receptor 
agonist) at doses of 0.1ug and 0.01ug significantly attenuated the shock sensitization of 
the acoustic startle response relative to the saline control animals. An ANOVA of the 
difference scores (post-shock – postdrug) confirmed the results of the repeated measures 
ANOVA in that the saline control group demonstrated significantly enhanced shock 
sensitization of the ASR in comparison with the 0.1ug and 0.01ug muscimol groups. An 
ANOVA of the shock reactivity between each group revealed no group differences in 
mean movement amplitudes (movement 100ms before and 100ms after receiving 
footshock). Therefore, the infusion of muscimol did not affect the animals’ ability to 
respond appropriately to the footshock, nor did it impair their ability to perceive the 
footshock as an aversive event.  
 
4.4 Dorsal Hippocampus  
  
 Intra dorsal hippocampal infusions of the drug muscimol (GABA A receptor 
agonist) at the measure of 0.1ug significantly attenuated the shock sensitization of the 
acoustic startle response relative to the saline control animals. An ANOVA of the 
difference scores (post-shock – postdrug) confirmed the results of the repeated measures 
ANOVA in that the saline control group demonstrated significantly enhanced shock 
sensitization of the ASR in comparison with the 0.1ug and 0.01ug muscimol groups. An 
ANOVA of the shock reactivity between each group revealed no group differences in 
mean movement amplitudes (movement 100ms before and 100ms after receiving 
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footshock). Therefore, the infusion of muscimol did not affect the animals’ ability to 
respond appropriately to the footshock, nor did it impair their ability to perceive the 
footshock as an aversive event.  
  
 The present results demonstrated that the inactivation of the BLA, and dorsal and 
ventral hippocampus with muscimol caused the attenuation of shock sensitization without 
any significant changes in shock reactivity. The drug muscimol is a direct agonist for the 
gamma – aminobututyric acid (GABA) binding site on the GABA A receptor (Nicoll, 
Malenka, & Kauer, 1989). GABA is an amino acid and is the most important inhibitory 
neurotransmitter in the CNS (Stachowicz, Klak, Klodińska, Chojnacka-Wόjcik, & Pilc, 
2006). GABA is produced from the glutamic acid action of the enzyme glutamic acid 
decarboxylase (GAD) that removes a carboxyl group. There are two GABA receptors 
namely, GABA A and GABA B. GABA A is ionotropic and controls the chloride 
channel, the GABA B receptor is metabotropic and controls the potassium channels. The 
GABA A receptors are quite complex in their design and contain at least five different 
binding sites. Muscimol is derived from the Ach agonist muscarine and serves as a direct 
agonist from the GABA site. Barbiturates, drugs that bind to the steroid site, and 
benzodiazepines all promote the activity of the GABA A receptor, and are therefore 
indirect agonists. Benzodiazepines are very effective anxiolytics and are termed ‘anxiety 
dissolving’ drugs which are used to treat patients suffering from severe anxiety disorders 
(Delaney & Sah, 1999; Marowsky, Fritschy, & Vogt, 2004).  
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 The inhibitory action of GABA has been identified as playing an important role in 
mediating neuronal excitation of the amygdala (Delaney & Sah, 1999; Marowsky et al., 
2004) and the hippocampus (Stachowicz et al., 2006; Berretta, Munno, & Benes, 2001; 
Bannerman et al., 2004; Corcoran & Maren, 2001; Bast et al., 2001). The present study’s 
results revealed an important finding that the infusion of the GABA A receptor agonist 
muscimol into the BLA, and dorsal and ventral hippocampus blocked the ability of 
footshock to increase the mean amplitude of the ASR in shock sensitization. The amount 
of drug diffusion that may have occurred with the drug muscimol was dependent on the 
volume, concentration, and time after the infusion was administered. The present study 
employed similar parameters to those used by Martin (1991) who reported drug diffusion 
of 1.7mm from the forebrain tissue injection site, subsequent to a 1.0ul infusion of 1.0ug 
of muscimol. The present experiment utilised volumes of 0.1ug and 0.01ug of the drug 
muscimol, which are one half of the volume used in the study carried out by Martin 
(1991). The behavioural effects were apparent with both low doses of muscimol in the 
amygdala, and dorsal and ventral hippocampus. Furthermore, it is important to note that 
the efficacy of low dose muscimol infusion in inhibiting shock sensitization of the ASR 
supports previous research that demonstrated reliable conditioned place preference after 
infusion of 0.005ug muscimol into the VTA (Laviolette & Van der Kooy, 2001; 2004).  
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4.5 The Amygdala and GABA A’s Involvement in Fear Arousal 
 
 The present study assessed the effects of rapid footshock on the ASR as a measure 
of fear arousal and the results confirmed the hypothesis that shock-associated fear 
involves a GABA mechanism in the BLA. The amygdala has been identified as an 
important structure for receiving important information regarding aversive events (such 
as footshock), interpreting that information, and the resultant expression of fear arousal is 
expressed. It has also been identified as an important structure for the acquisition and 
expression of fear and is widely accepted as playing an important role in the 
neurocircuitry involved in fear and anxiety. Research investigating the underlying neural 
networks of the ASR has implicated a number of brain areas involved. For example, 
lesions of the caudal granular, dysgranular cortex and the posterior intralaminar thalamic 
nuclei in Davis and Shi’s (1999) experiment demonstrated blocked shock sensitization of 
the ASR. Lesions of the periacqueductal grey (Fendt et al., 1994) and infusions of 
substance P (antagonist) into the caudal pontine reticular nucleus have also demonstrated 
attenuation of shock-potentiated startle which provides more insight into the startle 
circuitry within the brain stem (Krase, Koch, & Schnitzler, 1994). Both the 
periacqueductal grey (Gebhart, 2004) and the amygdala have been identified as 
modulators of pain (Helmstetter & Bellgowan, 1993). Differing tests of nociception, 
excitotoxic lesions, and muscimol infusions have demonstrated various effects revealing 
that the central nucleus of the amygdala, not the BLA is involved in processing 
information regarding fear from noxious stimuli (Manning, 1998; Manning, Martin, & 
Meng, 2003). Research involving lesions of the central and BLA have blocked shock 
sensitization of the ASR (Hitchcock, Sananes, & Davis, 1989; Sananes & Davis, 1992), 
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while excitotoxic lesions of the central amygdala attenuated shock induced hyperalgesia 
(Crown, King, Meagher, Grau, 2000). However, excititoxic lesions of the BLA do not 
show similar results.  
  
 Research involving electrolytic lesions of the central amygdala have shown 
reductions in the shock reactivity of rats after footshock (Hitchcock et al., 1989). The two 
doses of 0.1ug and 0.01ug of muscimol used in the present study did not have any effect 
on the animals’ footshock reactivity suggesting that shock perception in the BLA does 
not involve GABA neurotransmission. Previous research has shown that after classical 
fear conditioning takes place, the CS activates the neural representation of an US 
(Wagner & Brandon, 1989). Stork and colleagues (2002) found that lab mice that were 
exposed to a fear evoking CS exhibited a markedly reduced level of extracellular GABA 
in the amygdala. This observation lent further support to the view that there is a causal 
relationship between a decrease in GABA activity within the amygdala and during 
enhancement of fear. The results of the present study revealed that the GABA A receptor 
agonist muscimol attenuated the amplitude of the ASR after receiving fear provoking 
footshock, therefore suggesting that the amygdala and GABA are important underlying 
neural mechanisms that regulate the emotion of fear, which is activated by an aversive 
stimulus. The results of the experiment also lend further support to previous research 
demonstrating similar results (Van Nobelen & Kokkinidis, 2006). 
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 Research carried out by Liu and colleagues (2007) investigated the neurochemical 
mechanisms that underlie the effects of fearful cue presentations through the release of 
norepinepherine (NE) and GABA within the amygdala. Their results revealed that fearful 
cues such as footshock produce an altered release of NE and GABA within the amygdala 
two hours after initial presentation, which later recovered to normal levels four hours 
after the presentation of the fearful cue. Noradrenalin levels increased when a stressful 
event occurred, which in turn caused an increase in the release of NE within the 
amygdala. Intense footshock altered the release of NE after the presentation of the CS, 
while the administration of muscimol decreased the level of NE within the amygdala 
(Hatfield, Spanis, & McGaugh, 1999), suggesting that GABA regulates NE release. The 
results of Liu et al., (2007) demonstrated that fear-induced alterations exhibited in NE 
and GABA release in multiple brain areas influenced fear-induced changes in 
neurotransmitter release systems within the amygdala. In the current experiment animals 
received ten rapid presentations of mild electric footshock during the shock sensitization 
procedure. The animals experienced a stressful event in the chamber which increased 
their noradrenalin levels, resulting in an increase in NE within the amygdala. The 
infusion of muscimol into the amygdala decreased the level of NE within the amygdala 
suggesting that GABA regulates NE release. The GABA A receptor agonist muscimol 
blocked the increase of the ASR after receiving fear inducing footshock in the present 
study, therefore supporting Liu’s et al., (2007) research which suggests that the amygdala 
and GABA are important underlying neural mechanisms for regulating the emotion of 
fear and anxiety when activated by an aversive event.  
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4.6 The Dorsal and Ventral Hippocampus and GABA A’s Involvement in Fear 
 Arousal 
  
 GABA has been shown to play an important role in the inhibition of 
neurotransmitters in the hippocampus (Bast et al., 2001; Buzsaki, Horvath, Urioste, 
Hetke, & Wise, 1992 Cobb, Buhl, Halasy, Paulsen, & Somogyi, 1995). The present study 
revealed an important finding, namely, that the infusion of the GABA A receptor agonist 
muscimol into both the dorsal and ventral hippocampus blocked the magnitude of the 
ASR after the presentation of fear-provoking footshock. The majority of research has 
investigated involvement of the hippocampus in learning and memory and has 
concentrated on its role in Pavlovian fear conditioning. Research has demonstrated that 
lesions of the hippocampus reduce contextual freezing (Phillips & LeDoux 1992; 
LeDoux, 1993, Fendt & Fanselow, 1999; Antoniadis & McDonald, 2000; Bannerman et 
al., 2003; Bast et al., 2001) but not the fear-potentiated startle response (McNish et al., 
1997).  
 
 Major current views in understanding the roles of both the amygdala and 
hippocampus in fear conditioning to a context, include the first view states that the 
hippocampus is critical for stimulus selection during learning (Winocur, Rawlins, & 
Gray, 1987). Rats with hippocampal lesions tend to show an enhanced fear to a context 
after fear conditioning to a context takes place. A second view posits that the 
hippocampus relays contextual information through the amygdala’s fear circuitry that is 
associated with the unconditioned response to shock. This view suggests that the 
amygdala and hippocampus are interconnected (McDonald & White, 1993). Experiments 
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have shown that rats with damage to the amygdala are unable to acquire and retain 
conditioned fear to a cue and context paired with footshock (Kim & Fanselow, 1992; 
Phillips and LeDoux, 1992). Rats with hippocampal damage exhibit impairment in their 
ability to acquire conditioned fear to a context but not a cue paired with footshock 
(Blanchard & Fial, 1968).  
  
 Other researchers have suggested that the hippocampus and amygdala work 
independently to access unconditioned fear responses to footshock and that the ability to 
identify one’s environment and the context is retrieved by neurocircuitry of the 
hippocampus or amygdala. Supporting evidence for this assumption stems from research 
revealing that rats with hippocampal damage, demonstrate impairment in the acquisition 
of contextual fear conditioning (Helmestetter et al., 1993; Kim & Fanselow, 1992; 
Selden, Everitt, Jarrard, & Robbins, 1991; Sutherland & McDonald, 1990). The final 
view suggests that the hippocampus has a very limited role in contextual fear 
conditioning. Phillips and LeDoux (1994) state that the hippocampus is only necessary 
for contextual fear conditioning when there is a demand between a static context and 
predictive phasic cue. Research with rats that have hippocampal damage demonstrate 
impairments in contextual fear conditioning when there is competition between a cue and 
its context, but when contextual conditioning is static they show normal acquisition 
(Penick & Solomon, 1991; Phillips & LeDoux, 1994). Antoniadis and McDonald (2000) 
investigated eight different response measures of fear in order to assess the roles of the 
amygdala and hippocampus in fear conditioning to a context. Their results revealed that 
the amygdala is involved in learning and memory of fear conditioning to a context and to 
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the conditioning of heart rate. The hippocampus was identified in their experiment as a 
participant in learning and memory of fear conditioning to a context, and also to 
conditioned defecation and body temperature. Both the amygdala and hippocampus were 
identified as important for the conditioning of freezing, ultrasonic vocalizations, 
locomotion, and preference.  
  
 Antoniadis and McDonald (2000) proposed a different view of involvement of the 
amygdala and hippocampus in contextual fear conditioning. They suggested that the fear 
responses of freezing, urination, locomotion, and preference are ‘fast’ measures of fear 
which have been shown to discriminatively condition to a context after a single training 
session. On the other hand, ultrasonic vocalisations and defecation were seen as ‘slow’ 
measures of fear as they tend to require multiple training sessions to exhibit fear of a 
context. Heart rate was described as an ‘intermediate’ measure of fear that takes 20 
minutes to become apparent. Defecation and body temperature that are mediated by the 
hippocampus were viewed as ‘slow’ measures of fear. All these different measures of 
fear require the participation of both the hippocampus and amygdala. A pattern seems to 
emerge from Antoniadis and McDonald’s (2000) research which suggests that the 
hippocampus selectively regulates the ‘slow’ fear measures, while the amygdala 
selectively mediates ‘intermediate’ fear measures. However, both of these memory 
structures interact together in order to modulate the ‘fast’ measures of locomotion, 
freezing, and preference, as well as the ‘slow’ measure of ultrasonic vocalisations. The 
present study demonstrated that a few presentations of mild footshock attenuated the 
ASR of rats after muscimol infusions into the amgydala, and dorsal and ventral 
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hippocampus. We propose that the shock sensitization paradigm used in this study can be 
viewed as a ‘fast’ measure of fear which provides further support for Antoniadis and 
McDonald’s (2000) suggestion that the hippocampus and amygdala interact in order to 
modulate ‘fast’ measures of fear; that is the shock sensitization paradigm in the current 
experiment. 
  
 Research involving microinfusions of various drugs including muscimol into 
either the dorsal or ventral hippocampus have tended to attenuate the startle response, 
block freezing after receiving contextual fear conditioning (Bast et al., 2001; Wan et al., 
1996; Zhang et al., 2000; Zhang et al;., 2002), and decrease the rate of extinction after 
receiving Pavlovian fear conditioning (Corcoran & Maren, 2001; Cocoran, Desmond, 
Frey, & Maren, 2005). Bast and his colleagues (2001) found that the inhibitory action of 
GABA A receptors via muscimol infusion into the ventral hippocampus disrupted the 
ability for laboratory rats to fear condition to a context. Therefore, the current study lends 
further support for the view that a there is a causal relationship between a decrease in 
GABA activity within the hippocampus and the enhancement of fear. This is because rats 
with muscimol microinfusions into the dorsal and ventral hippocampus exhibited a 
decrease in their ASR amplitudes after receiving fear inducing electric footshock.  
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4.7 Is sensitization a conditioned or unconditioned form of aversive information 
 processing?     
 
 Sensitization is thought to be a process of non-associative learning because the 
animal does not associate a specific event with an aversive stimulus. However, several 
researchers have suggested that some sort of associative learning takes place, such as a 
rapid conditioning to the context or background cues (Pilz & Schnitzler, 1996). Davis 
designed a specific experiment for investigating the conditioning of background cues and 
how they affected the ASR. The experiment made use of varied and constant lighting 
conditions. His results demonstrated that both groups of rats exhibited similar enhanced 
ASR potentiation after receiving footshock (Davis, 1989). Davis concluded that 
background conditioning does not contribute significantly to the enhancement of the ASR 
by footshock (Davis, 1989).  
  
 In contrast, research carried out by Richardson and Elsayed (1998) demonstrated 
that shock sensitization of the ASR is mediated by contextual conditioning. Therefore, 
the varying sensitization experiments have produced mixed results as to whether 
sensitization is a process of non-associative or associative learning. However, Van 
Nobelen and Kokkinidis (2006) examined the shock sensitization paradigm using 
laboratory rats that received infusions of saline, AP5, CNQX, anisomycin, and muscimol 
(0.0001ug) into the amygdala. They demonstrated robust shock sensitization of the ASR 
despite pre-exposure to the apparatus in dB selection testing, pre-drug testing, and post-
drug testing prior to receiving the presentation of footshock.  
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 Currently there is no literature demonstrating that fear-potentiated startle rapidly 
conditions to an explicit CS after a single pairing of the CS-US. This is unlike the fear 
response of defensive freezing that is proposed to be a learned response to a context 
which is evident after a single pairing of the CS-US (Fanselow, 1980; LeDoux, 2000). 
The present study used a similar paradigm to that of Van Nobelen and Kokkinidis (2006) 
in that laboratory rats in saline and muscimol groups (0.1ug & 0.01ug) exhibited robust 
shock sensitization amplitudes following pre-exposure to the procedural apparatus during 
dB selsction testing, predrug baselining testing, and postdrug testing. Therefore, it is 
proposed that the experimental procedure used in the present experiment did not result in 
rapid fear conditioning to the context, suggesting that the observed shock augmentation 
of startle amplitudes reflected an objective measure of ‘fast’ or rapid fear arousal brought 
on by the US.  
  
 The amygdala has been strongly implicated in the acquisition, expression and 
conditioning of fear. If sensitization is a form of associative learning or contextual 
conditioning then we would not have expected to observe attenuation of dorsal and 
ventral hippocampus with the drug muscimol after shock sensitization as the 
hippocampus has not been shown to be involved in fear potentiation of the ASR. The 
current study demonstrated that muscimol infusions into the amygdala, and dorsal and 
ventral hippocampus blocked shock sensitization thereby providing further support for 
the premise that sensitization is a non-associative form of learning and may involve both 
the amygdala and hippocampus (Van Nobelen and Kokkinidis, 2006). 
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4.8 Clinical Implications 
  
 The present study demonstrated that muscimol infusions into the amygdala, and 
dorsal and ventral hippocampus attenuated shock sensitization of the ASR, which may 
further the understanding of the neural basis of psychological disorders associated with 
disturbances in fear and anxiety. The development of many psychological disorders is 
influenced by anxiety-related stressful experiences (Davidson, Tupler, Wilson, & Comer, 
1998). The inhibitory actions of GABA interneurons have been implicated in the 
physiology of the hippocampus (Buzsaki et al., 1995; Cobb et al., 1995; Whittington, 
Traub, & Jefferys, 1995; Freund & Gulyas, 1997; Sik, Penntonen, & Buzsaki, 1997; 
Zhang et al., 1998; Csicsvari, Hirase, Czurko, Mamiya, & Buzsaki, 1999). The 
interneurons in the hippocampus have been suggested to control the long-term 
modifications of synaptic transmission and the regulation of phenotypical differentiation 
during development of the brain (Marty, Berninger, Carroll, Thoenen, 1996). Therefore, 
it is thought that pathological alterations of GABA neurons within the hippocampus are 
associated with its physiological functions, and as a result be connected with other 
structures within the corticolimbic system (Berretta et al., 2001).  
  
 Schizophrenia is a human brain disorder associates with corticolimbic regions, 
most commonly the hippocampus where complex neurocircuitry changes occur (Arnold 
& Trojanowki, 1996; Benes, 1999). Abnormalities identified in the schizophrenic’s 
hippocampus are a general decrease in GABA neuronal activity in the CA4, CA3, CA2, 
but not the CA1 regions. A similar finding is observed in neuroleptic free patients. 
Therefore, the decrease in GABA activity is unlikely to be brought on by the use of anti-
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psychotic drugs. The amygdala and hippocampus have been proposed as the strongest 
candidates for abnormal activity within these structures of schizophrenic sufferers. The 
amygdala and hippocampus are intimately connected by coherent theta oscillations, 
therefore suggesting an interaction between the two structures (Paré & Gaudreau, 1996). 
Imaging studies have consistently found changes in both the hippocampus and amygdala 
in schizophrenic patients (Shenton, Kikinis, Jolesc, Pollak, LeMay, Wible, Hokama, 
Martin, Metcalf, Coleman, & McCarley, 1992; Bogerts, Lieberman, Ashtari, Bilder, 
Degreef, Lerner, Johns, & Masiar, 1993; Marsh, Suddath, Higgins, & Weinberger, 1994). 
Therefore, research supports the hypothesis that the amygdala may influence the 
abnormalities found in the hippocampus of the schizophrenic brain. The results of the 
present study may help further understand the mechanisms underlying the symptoms and 
etiology of schizophrenia. Berretta and his colleagues (2001) suggest that the 
hippocampus and amygdala are interconnected especially in regards to GABA activity 
which in turn supports the results of the present experiement that demonstrated GABA A 
activity within the amygdala and hippocampus. Accumulating evidence supports the view 
that changes in the schizophrenic hippocampus in early adulthood maybe due to 
abnormal GABA activity in the amygdala. 
  
 GABA is a major inhibitory neurotransmitter in the CNS (Nicoll et al., 1989). 
GABA A receptors gate the chloride ionophore channels and have binding sites for 
benzodiazepines, barbiturates, and anaesthetics which potentiate the GABA response 
(MacDonald & Olsen, 1994; Johnston, 1996). Benzodiazepines, which are commonly 
used to treat patients suffering from anxiety, are thought to enhance the action of GABA 
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in the brain (Tallman & Gallager, 1985; Costa & Guidotti, 1996). Benzodiazepines are 
the most popular medications used to treat anxiety-related disorders and are thought to 
act on GABA at the GABA A receptors. The amygdala is the key structure in the brain 
that has been identified as processing emotional information and generating fear arousal 
and responding (LeDoux, 1996). A dysfunction in the amygdala has been proposed to be 
the causal mechanism underlying anxiety-related disorders (Tallman & Gallager, 1985; 
Costa & Guidotti, 1996; Davis, 1992; LeDoux 1995). The present results establish the 
importance of the amygdala, hippocampus and GABA activation in fear inducing events 
which indicate that the amygdala and hippocampus may be potential sites for further 
investigation of the neural mechanisms involved in anxiety-related psychological 
disorders.   
              
4.9 Future Research  
 
 Future research should further investigate effects of lower doses of muscimol on 
the hippocampus and amygdala in order to determine the role that GABA 
neurotransmission plays within the neural circuitry of fear learning and memory. Further 
research could also study the possible relationship between the amygdala, hippocampus 
and GABA in the fear-potentiated startle response following Pavlovian conditioning, as 
most research involving fear conditioning has been confined to the fear measure of 
freezing. It would be interesting to see if the results would be similar to those 
demonstrated in the present study.  
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 Disorders of fear acquisition and expression are thought to underlie mental 
complaints such as panic attacks, anxiety, schizophrenia, depression, and PTSD. 
Research involving various anxiolytic drugs such as benzodiazepines, has not resulted in 
any major breakthroughs since first being introduced 50 years ago. Benzodiazepines used 
for treating anxiety are thought to enhance the inhibitory action of GABA in the brain. 
Previous research has resulted in a focus on two major brain transmitters GABA 
(inhibitory) and glutamate (excitatory). The hippocampus has been identified as being 
involved in the regulation of anxiety-related behaviour (Gray, 1982; Stachowicz et al., 
2006). The present study revealed that the amygdala and hippocampus have varying 
GABA actions in the brain. Therefore further research needs to be carried out in order to 
understand GABA’s actions within the amygdala and hippocampus thereby advancing 
understanding of the nature, development, and treatment of anxiety-and fear-related 
disorders.    
 
4.10 Summary 
  
 Previous research has demonstrated that pretraining infusion of muscimol into the 
lateral and basolateral amygdala interferes with Pavlovian fear conditioning (Helmstetter 
& Bellgowan, 1994). The present study found that postshock fear can be reliably 
inhibited by administration of the GABA A agonist muscimol into the BLA, and dorsal 
and ventral hippocampus. As GABA A receptors did not mediate shock reactivity or the 
amplitude of the ASR in the BLA, dorsal, and ventral hippocampus, it can be reasonably 
concluded that GABA neurotransmission within the amygdala and hippocampus may be 
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an essential component modulating the fear arousal produced by footshock.  The results 
of the current experiment suggest that both the dorsal and ventral hippocampus play a 
larger role in the emotion of fear than initially believed. It would appear that the 
amygdala and its limbic counterparts all take part in the initial stages of fear arousal. The 
amygdala, dorsal and ventral hippocampus have been identified as critical brain 
structures involving GABA neurotransmission in the unconditioned shock sensitization 
paradigm. Shock sensitization has been represented as a rapid state of fear that can be 
expressed and measured through an animal’s enhancement of the ASR. 
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